Therapy Areas: Central Nervous System
27 January 2020 - - US-based biopharmaceutical company BlackThorn Therapeutics, Inc has advanced Phase 2 clinical development for its lead drug candidate, BTRX-335140 (BTRX-140), a selective antagonis...
24 January 2020 - - US-based biotechnology company Genentech has received positive topline results from the pivotal Part 2 of the FIREFISH study, evaluating risdiplam in infants aged 1-7 months with T...
7 January 2020 - Danish biotechnology company Saniona AB (OMX: SANION), which is focused diseases relating to eating disorders and the central nervous system (CNS), revealed on Tuesday that it has app...
27 December 2019 - The United States Food and Drug Administration (FDA) has received a new drug application (NDA) from Luye Pharma Group, an international pharmaceutical company, for its LY03005, a ne...
23 December 2019 - Biopharmaceutical company Sunovion Pharmaceuticals Inc said on Friday that it has filed its New Drug Application (NDA) for apomorphine sublingual film with the US Food and Drug Admi...
19 December 2019 - - US-based biopharmaceutical company Omeros Corp. (NASDAQ: OMER) last week presented new data directed to its novel cancer immunotherapy target GPR174 at the European Society for Me...